ABVC BioPharma Acquires Taiwan Land for $11 Million
I'm PortAI, I can summarize articles.
ABVC BioPharma Inc. has completed two land acquisitions in Taiwan for approximately $11 million. The investments include $7.67 million for a plant factory in Puli for botanical raw materials and drug research, and $3.3 million for agricultural R&D in Longtan. These acquisitions aim to enhance the company's research and manufacturing capabilities in Asia.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments